Drug Use-Results Survey of Betanis Tablets 25 and 50 mg
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society
- 02 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 21 May 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.